Miguel Cantu, M.D. Assistant Professor School Medical School Department Pathology You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Dr. Miguel Dario Cantu, MD is a hematopathologist and molecular pathologist at the University of Texas Southwestern where he serves as Assistant Professor of Pathology and Hematopathology Course Director for medical school and pathology residency courses at UTSW. Dr. Cantu is a native of the Rio Grande Valley in South Texas. He graduated summa cum laude from the University of Texas Pan-American with a Bachelor of Science in Biology. He completed his medical training at the University of Texas Health Science Center at Houston’s McGovern Medical School with a scholarly concentration in Molecular and Translational Medicine (2012-2016). He completed an Anatomic and Clinical Pathology Residency at New York Presbyterian – Weill Cornell in New York City (2016-2020) where he served as Assistant Chief Resident and Chief Resident of Anatomic Pathology. He pursued additional fellowship training in Hematopathology at New York Presbyterian—Weill Cornell (2020-2021) followed by a Molecular Genetic Pathology fellowship at the University of Texas Southwestern (2021-2022). Dr. Cantu is board certified by the American Board of Pathology in Anatomic and Clinical Pathology, Hematopathology, and Molecular Genetic Pathology. His clinical research interests include the study of the molecular pathogenesis of myeloid and lymphoid neoplasms with a particular interest in immunodeficiency-associated lymphoproliferative disorders. During his training, Dr. Cantu was a 2021 ASCP 40 Under 40 honoree and received the 2022 Pathologist-in-Training Award from the Society for Hematopathology and the Dr. Janet Caldwell Fellow Research Award for his work studying therapy-related myeloid neoplasms. Education Medical School McGovern Medical School at the University of Texas Health Science Center at Houston (2016) Residency New York Presbyterian Hospital - Weill Cornell Medical Center (2020), Anatomic & Clinical Pathology Fellowship New York Presbyterian Hospital - Weill Cornell Medical Center (2021), Hematopathology Fellowship UT Southwestern Medical Center (2022), Molecular Genetics Publications Featured Publications Impact of myelodysplasia-related mutations on 2022 European LeukemiaNet genetic risk classification in de novo acute myeloid leukemia with normal karyotype. Shanker S, Hasserjian RP, Madanat Y, Weinberg OK, Cantu MD, Am J Hematol 2024 Oct Genomic heterogeneity within B/T mixed phenotype acute leukemia in a context of an immunophenotype. Zheng R, Fuda F, Gagan JR, Weinberg OK, Koduru P, Cantu M, Ludwig K, Truscott JM, Collins R, Chung S, Madanat YF, Chen W, Leuk Res Rep 2024 21 100410 Presence but not number of secondary type mutations influences outcome in de novo AML without MDS-associated or recurring cytogenetic abnormalities. Weinberg OK, Cantu MD, Gagan J, Madanat YF, Arber DA, Hasserjian RP, EJHaem 2023 Aug 4 3 760-764 Pancytopenia and haematopoietic precursor vacuolisation in an infant: Clues to Pearson syndrome. Driskill JH, Cantu MD, Garcia J, Dickerson KE, Chen W, Br J Haematol 2023 Jul Updates in molecular genetics of therapy-related myeloid neoplasms. Cantu MD, Semin Diagn Pathol 2023 May 40 3 182-186 Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group. Cantu MD, Kanagal-Shamanna R, Wang SA, Kadia T, Bueso-Ramos CE, Patel SS, Geyer JT, Tam W, Madanat Y, Li P, George TI, Nichols MM, Rogers HJ, Liu YC, Aggarwal N, Kurzer JH, Maracaja DLV, Hsi ED, Zaiem F, Babu D, Foucar K, Laczko D, Bagg A, Orazi A, Arber DA, Hasserjian RP, Weinberg OK, JCO Precis Oncol 2023 Jan 7 e2200400 Standardized Comparison of Different DNA Sequencing Platforms. Cantu M, Morrison MA, Gagan J, Clin Chem 2022 07 68 7 872-876 Advances in Diagnosis of Mitochondrial Diseases: Case Report of an Infant with Pearson Syndrome Cohen L, Rodriquez-Barreto AM, Cantu MD, McGuinn C, Ouseph M, Patel S, Kaicker S International Journal of Case Reports 2021 SARS-CoV-2 antibody characterization in emergency department, hospitalized and convalescent patients by two semi-quantitative immunoassays. Yang HS, Racine-Brzostek SE, Lee WT, Hunt D, Yee J, Chen Z, Kubiak J, Cantu M, Hatem L, Zhong E, D'Ambrosio D, Chadburn A, Westblade L, Glesby M, Loda M, Cushing MM, Zhao Z, Clin Chim Acta 2020 Oct 509 117-125 Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study. Rogers HJ, Wang X, Xie Y, Davis AR, Thakral B, Wang SA, Borthakur G, Cantu MD, Margolskee EM, Philip JKS, Sukhanova M, Bagg A, Bueso-Ramos CE, Orazi A, Arber DA, Hsi ED, Hasserjian RP, Am J Hematol 2020 07 95 7 799-808 Results 1-10 of 14 1 2 Next Last
